Diane E. Milenic

7.1k total citations · 1 hit paper
113 papers, 5.8k citations indexed

About

Diane E. Milenic is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Molecular Biology. According to data from OpenAlex, Diane E. Milenic has authored 113 papers receiving a total of 5.8k indexed citations (citations by other indexed papers that have themselves been cited), including 100 papers in Radiology, Nuclear Medicine and Imaging, 38 papers in Oncology and 34 papers in Molecular Biology. Recurrent topics in Diane E. Milenic's work include Radiopharmaceutical Chemistry and Applications (84 papers), Monoclonal and Polyclonal Antibodies Research (55 papers) and Medical Imaging Techniques and Applications (15 papers). Diane E. Milenic is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (84 papers), Monoclonal and Polyclonal Antibodies Research (55 papers) and Medical Imaging Techniques and Applications (15 papers). Diane E. Milenic collaborates with scholars based in United States, India and Slovakia. Diane E. Milenic's co-authors include Martin W. Brechbiel, Takashi Yokota, Kayhan Garmestani, Marc Whitlow, Kwamena E. Baidoo, Jeffrey Schlom, Erik D. Brady, Jeffrey Schlom, David Colcher and Tapan K. Nayak and has published in prestigious journals such as Journal of Clinical Oncology, Nano Letters and The Journal of Immunology.

In The Last Decade

Diane E. Milenic

113 papers receiving 5.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Rapid tumor penetration of a single-chain Fv and comparison with other immunoglobulin forms.

1992 691 citations Diane E. Milenic, Jeffrey Schlom et al. PubMed profile →

Peers

Diane E. Milenic

RNMI

ONCOL

PRM

IMMUN

Guus A.M.S. van Dongen Netherlands

Chang H. Paik United States

André Pèlegrin France

Sridhar Nimmagadda United States

Raymond M. Reilly Canada

Anna Orlova Sweden

David Colcher United States

Jörgen Carlsson Sweden

Buck E. Rogers United States

Roland Haubner Germany

Guus A.M.S. van Dongen Netherlands

Diane E. Milenic

5.0k ×1.1

RNMI

2.4k ×1.3

2.9k ×1.8

ONCOL

2.0k ×2.0

PRM

912 ×1.3

IMMUN

Citations per year, relative to Diane E. Milenic Diane E. Milenic (= 1×) peers Guus A.M.S. van Dongen

Countries citing papers authored by Diane E. Milenic

Since Specialization

Citations

This map shows the geographic impact of Diane E. Milenic's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Diane E. Milenic with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Diane E. Milenic more than expected).

Fields of papers citing papers by Diane E. Milenic

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Diane E. Milenic. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Diane E. Milenic. The network helps show where Diane E. Milenic may publish in the future.

Co-authorship network of co-authors of Diane E. Milenic

This figure shows the co-authorship network connecting the top 25 collaborators of Diane E. Milenic. A scholar is included among the top collaborators of Diane E. Milenic based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Diane E. Milenic. Diane E. Milenic is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Milenic, Diane E., et al.. (2017). Targeted α-Particle Radiation Therapy of HER1-Positive Disseminated Intraperitoneal Disease: An Investigation of the Human Anti-EGFR Monoclonal Antibody, Panitumumab. Translational Oncology. 10(4). 535–545. 17 indexed citations

Kim, Young‐Seung, Yang Zhou, Henry L. Bryant, et al.. (2015). Synthesis and characterization of gadolinium—Peptidomimetic complex as an αvβ3 integrin targeted MR contrast agent. Bioorganic & Medicinal Chemistry Letters. 25(10). 2056–2059. 7 indexed citations

Nayak, Tapan K., Marcelino Bernardo, Diane E. Milenic, Peter L. Choyke, & Martin W. Brechbiel. (2013). Orthotopic Pleural Mesothelioma in Mice: SPECT/CT and MR Imaging with HER1- and HER2-targeted Radiolabeled Antibodies. Radiology. 267(1). 173–182. 12 indexed citations

Kang, Chi Soo, Hyun A. Song, Diane E. Milenic, et al.. (2013). Preclinical evaluation of NETA-based bifunctional ligand for radioimmunotherapy applications using 212Bi and 213Bi: Radiolabeling, serum stability, and biodistribution and tumor uptake studies. Nuclear Medicine and Biology. 40(5). 600–605. 41 indexed citations

Baidoo, Kwamena E., Diane E. Milenic, & Martin W. Brechbiel. (2013). Methodology for labeling proteins and peptides with lead-212 (212Pb). Nuclear Medicine and Biology. 40(5). 592–599. 55 indexed citations

Nwe, Kido, Diane E. Milenic, L. Henry Bryant, Celeste A.S. Regino, & Martin W. Brechbiel. (2011). Preparation, characterization and in vivo assessment of Gd-albumin and Gd-dendrimer conjugates as intravascular contrast-enhancing agents for MRI. Journal of Inorganic Biochemistry. 105(5). 722–727. 27 indexed citations

Wong, Karen, Kwamena E. Baidoo, Tapan K. Nayak, et al.. (2011). In vitro and in vivo pre-clinical analysis of a F(ab')2 fragment of panitumumab for molecular imaging and therapy of HER1-positive cancers. EJNMMI Research. 1(1). 77 indexed citations

Regino, Celeste A.S., Karen Wong, Diane E. Milenic, et al.. (2009). Preclinical Evaluation of a Monoclonal Antibody (3C6) Specific for Prostate-Specific Membrane Antigen. Current Radiopharmaceuticals. 2(1). 9–17. 21 indexed citations

Milenic, Diane E., Karen Wong, Kwamena E. Baidoo, et al.. (2008). Cetuximab: Preclinical Evaluation of a Monoclonal Antibody Targeting EGFR for Radioimmunodiagnostic and Radioimmunotherapeutic Applications. Cancer Biotherapy and Radiopharmaceuticals. 23(5). 619–632. 59 indexed citations

10.

Boswell, C. Andrew, Celeste A.S. Regino, Kwamena E. Baidoo, et al.. (2008). A novel side-bridged hybrid phosphonate/acetate pendant cyclam: Synthesis, characterization, and 64Cu small animal PET imaging. Bioorganic & Medicinal Chemistry. 17(2). 548–552. 28 indexed citations

11.

Chong, Hyun‐Soon, Diane E. Milenic, Kayhan Garmestani, et al.. (2006). In vitro and in vivo evaluation of novel ligands for radioimmunotherapy. Nuclear Medicine and Biology. 33(4). 459–467. 34 indexed citations

12.

Garmestani, Kayhan, Diane E. Milenic, Erik D. Brady, Paul S. Plascjak, & Martin W. Brechbiel. (2005). Purification of cyclotron-produced 203Pb for labeling Herceptin. Nuclear Medicine and Biology. 32(3). 301–305. 19 indexed citations

13.

Milenic, Diane E., Mario Roselli, Saed Mirzadeh, et al.. (2001). In Vivo Evaluation of Bismuth-Labeled Monoclonal Antibody Comparing DTPA-Derived Bifunctional Chelates. Cancer Biotherapy and Radiopharmaceuticals. 16(2). 133–146. 51 indexed citations

14.

Tamura, Midori, Diane E. Milenic, Makoto Iwahashi, et al.. (2000). Structural Correlates of an Anticarcinoma Antibody: Identification of Specificity-Determining Residues (SDRs) and Development of a Minimally Immunogenic Antibody Variant by Retention of SDRs Only. The Journal of Immunology. 164(3). 1432–1441. 45 indexed citations

15.

Milenic, Diane E.. (2000). Radioimmunotherapy: Designer molecules to potentiate effective therapy. Seminars in Radiation Oncology. 10(2). 139–155. 18 indexed citations

16.

Chappell, Lara L., Ekaterina Dadachova, Diane E. Milenic, et al.. (2000). Synthesis, characterization, and evaluation of a novel bifunctional chelating agent for the lead isotopes 203Pb and 212Pb. Nuclear Medicine and Biology. 27(1). 93–100. 123 indexed citations

17.

Iwahashi, Makoto, Diane E. Milenic, Eduardo A. Padlan, et al.. (1999). CDR substitutions of a humanized monoclonal antibody (CC49): contributions of individual CDRs to antigen binding and immunogenicity. Molecular Immunology. 36(15-16). 1079–1091. 26 indexed citations

18.

Schlom, Jeffrey, Kathleen Siler, Diane E. Milenic, et al.. (1991). Monoclonal antibody-based therapy of a human tumor xenograft with a 177lutetium-labeled immunoconjugate.. PubMed. 51(11). 2889–96. 95 indexed citations

19.

Colcher, David, et al.. (1991). In vivo and in vitro clinical applications of monoclonal antibodies against TAG-72. International Journal of Radiation Applications and Instrumentation Part B Nuclear Medicine and Biology. 18(4). 395–401. 7 indexed citations

20.

Colcher, David, Robert E. Bird, Mario Roselli, et al.. (1990). In Vivo Tumor Targeting of a Recombinant Single-Chain Antigen-Binding Protein. JNCI Journal of the National Cancer Institute. 82(14). 1191–1197. 250 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact